Biopreservation plays an important role in healthcare and food industry. It helps to preserve the biological product or material. It uses natural flora of biological material or the products of natural flora to preserve the product. The increasing expenditure on healthcare, a growing number of in vitro fertilization (IVF) centers, increasing awareness about stem cell and its applications are the major factors driving the growth of the global biopreservation market.
Additionally, increasing R&D spending and aggressive strategies adopted by the top players, such as mergers and acquisitions are contributing to the growth of the market. For instance, in March 2016, Shanghai Genext Medical Technology Co Ltd announced the acquisition of a US-based Lifeline Scientific for USD 87.8 million this acquisition will help Shanghai Genext Medical Technology to enter into the clinical transplant business.
The high cost associated with Biopreservation and biobanking instruments and its maintenance, stability issues related to the specimen and lack of skilled personnel for handling the biopreservation process may hamper the growth of the market during the assessment period.
Segmentation
The global biopreservation market growth has been segmented based on product, biospecimen, and application.
By Product
- Media
- Nutrient media
- Sera
- Supplements
- Equipment
- Temperature control systems
- Accessories
- Alarms & monitoring systems
- Incubators
- Centrifuges
- Other equipment
By Biospecimen
- Human tissue samples
- Organs
- Stem cells
- Other biospecimens
By Source
- Regenerative medicine
- Cell therapy
- Gene therapy
- Others
- Biobanking
- Human egg
- Human sperm
- Veterinary ivf
Key Players
Some of the key players in the global biopreservation market are
- Thermo Fisher Scientific, Inc
- VWR International, LLC.
- CUSTOM BIOGENIC SYSTEMS.
- BioLifeSolutions Inc.
- BioCision
- Sigma-Aldrich Co.
- QIAGEN
- Lifeline Scientific
- Cesca Therapeutics Inc.
- Core Dynamics, Ltd.
- Princeton CryoTech
- Biomatrica, Inc.
- Panasonic Biomedical, Inc.
- Chart Industries
- ATLANTA BIOLOGICALS.
Regional Analysis
The market in the Americas is expected to dominate the global biopreservation market during the forecast period owing to the increasing organ transplantation, increasing healthcare expenditure, and well-established healthcare sector in the region.
The European market is expected to be the second-largest due to government funding and support of the healthcare sector and an increasing number of births and with-it continuous increase in demand for umbilical cord preservation.
The market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to technological development, increasing awareness about stem cell and its applications, and favorable government initiatives for healthcare facilities. The market in the Middle East & Africa is likely to account for the smallest share of the global biopreservation market. The market growth in this region can be attributed to increasing healthcare expenditure and technological advancement in the region.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future (MRFR) team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian